Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Spotlight Correspondence
  • Published:

Clonal Ph-negative hematopoiesis in CML after therapy with imatinib mesylate is frequently characterized by trisomy 8

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

References

  1. Kalidas M, Kantarjian H, Talpaz M . Chronic myeloid leukemia JAMA 2001 286: 895–898

    Article  CAS  Google Scholar 

  2. Hehlmann R, Heimpel H, Hasford J, Kolb HJ, Pralle H, Hossfeld DK, Queisser W, Loffler H, Heinze B, Georgii A . Randomized comparison of busulfan and hydroxurea in chronic myelogeneous leukaemia: prolongation of survival by hydroxurea. The German CML Study Group Blood 1993 82: 398–407

    CAS  PubMed  Google Scholar 

  3. Hehlman R, Heimpel H, Hasford J, Kolb HJ, Pralle H, Hossfeld DK, Queisser W, Loffler H, Hochhaus A, Heinze B . Randomized comparison of interferon-alpha with busulfan and hydroxurea in chronic myelogeneous leukaemia. The German CML Study Group Blood 1994 84: 4064–4077

    Google Scholar 

  4. Talpaz M, Kantarjian HM, McCredie K, Trujillo JM, Keating MJ, Gutterman JU . Hematologic remission and cytogenetic improvement induced by recombinant human interferon alpha A in chronic myelogeneous leukemia N Engl J Med 1986 314: 1065–1069

    Article  CAS  Google Scholar 

  5. Druker BJ, Talpaz M, Resta DJ, Peng B, Buchdunger E, Ford JM, Lydon NB, Kantarjian H, Capdeville R, Ohno-Jones S, Sawyers CL . Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia N Engl J Med 2001 344: 1031–1037

    Article  CAS  Google Scholar 

  6. Mahon FX, Delbrel X, Cony-Makhoul P, Faberes C, Boiron JM, Barthe C, Bilhou-Nabera C, Pigneux A, Mait G, Reiffers J . Follow-up of complete cytogenetic remission in patients with chronic myeloid leukemia after cessation of interferon alfa J Clin Oncol 2002 20: 214–220

    Article  CAS  Google Scholar 

  7. Horowitz MM, Rowlings PA, Passweg JR . Allogeneic bone marrow transplantation for CML: a report from the International Bone Marrow Transplant Registry Bone Marrow Transplant 1996 17 (Suppl. 3): S5–S6

    Google Scholar 

  8. Casali M, Truglio F, Milone G, Di Raimondo F, Parrinello G, Maserati E, Pasquali F . Trisomy 8 in Philadelphia chromosome (Ph1)-negative cells in the course of Ph1-positive chronic myelocytic leukemia Genes Chromosomes Cancer 1992 4: 269–270

    Article  CAS  Google Scholar 

  9. Bilhou-Nabera C, Marit G, Devianne I, Viard F, Salzes S, Montastruc M, Renoux M, Broustet A, Reiffers J, Bernard P . A second case of trisomy 8 in Philadelphia chromosome (Ph)-negative cells during the course of Ph-positive chronic myelocytic leukemia Genes Chromosomes Cancer 1993 4: 255–256

    Article  Google Scholar 

  10. Ariyama T, Inazawa J, Uemura Y, Kakazu N, Maekawa T, Urase F, Irimajiri K, Horiuchi A, Nakamura Y, Abe T . Clonal origin of Philadelphia chromosome negative cells with trisomy 8 appearing during the course of α-interferon therapy for Ph positive chronic myelocytic leukemia Cancer Genet Cytogenet 1995 81: 20–23

    Article  CAS  Google Scholar 

  11. Ohtsuka E, Kikuchi H, Abe Y, Moriyama K, Ohno E, Hirota K, Tezono K, Nasu M . Acute myeloblastic leukaemia without Philadelphia chromosome developing after interferon therapy for chronic myelocytic leukaemia with Philadelphia chromosome Br J Haematol 1995 90: 951–953

    Article  CAS  Google Scholar 

  12. Izumi T, Imagawa S, Hatake K, Miura Y, Ariyama T, Inazawa J, Abe T . Philadelphia chromosome-negative cells with trisomy 8 after busulfan and interferon treatment of Ph1-positive chronic myelogenous leukemia Int J Hematol 1996 64: 73–77

    Article  CAS  Google Scholar 

  13. Fayad L, Kantarjian H, O'Brien S, Seong D, Keating M, Talpaz M . Emergence of new clonal abnormalities following interferon-alpha induced complete cytogenetic response in patients with chronic myeloid leukemia: report of three cases Leukemia 1997 11: 767–771

    Article  CAS  Google Scholar 

  14. Marktel S, Bua M, Marin D, Chase A, Udom C, Armstrong L, Apperley JF, Olavarria E, Goldman JM . Emergence of additional chromosomal abnormalities following treatment with STI571 (Imatinib Mesylate) for Philadelphia positive chronic myeloid leukemia in chronic phase Blood 2001 98: 617a (Abstra. 2584)

    Google Scholar 

  15. Gambacorti-Passeri C, Giudici G, le Coutre P, Bungaro S, Pogliani EM, Kreuzer K-A, Tornaghi L, Alberti D, Corneo G, Biondi A . Non random chromosomal abnormalities in Ph-negative bone marrow (BM) cells from CML patients achieving major cytogenetic responses (MCR) with STI571 (Gleevec™) Blood 2001 98: 257b (Abstr. 4762)

    Article  Google Scholar 

  16. Meunier V, Giraudier S, Van den Akker J, Perot C, Jouault H, Caron-Servan B, Robin V, Tulliez M, Imbert M . Treatment with STI571 (Novartis®) in chronic myeloid leukemia (CML): unexpected hematological findings in a series of 26 patients Blood 2001 98: 263b (Abstr. 4784)

    Google Scholar 

  17. Fialkow PJ, Martin PJ, Najfeld V, Penfold GK, Jacobsen RJ, Hansen JA . Evidence for a multistep pathogenesis of chronic myelogeneous leukemia Blood 1981 58: 158–163

    CAS  PubMed  Google Scholar 

  18. Raskind WH, Ferraris AM, Najfeld V, Jacobsen RJ, Moohr JW, Fialkow PJ . Further evidence of a clonal Ph-negative stage in some cases of Ph-positive chronic myelocytic leukemia Leukemia 1993 7: 1163–1167

    CAS  PubMed  Google Scholar 

  19. Ferraris AM, Canepa L, Melani C, Miglino M, Broccia G, Gaetani GF . Clonal B lymphocytes lack bcr rearrangement in Ph-positive chronic myelogenous leukaemia Br J Haematol 1989 73: 48–50

    Article  CAS  Google Scholar 

  20. Lisker R, Casas L, Mutchinick O, Perez-Chavez F, Labardini J . Late-appearing Philadelphia chromosome in two patients with chronic myelogenous leukemia Blood 1980 56: 812–814

    CAS  PubMed  Google Scholar 

  21. Virtaneva K, Wright FA, Tanner SM, Yuan B, Lemon WJ, Caligiuri MA, Bloomfield CD, de La Chapelle A, Krahe R . Expression profiling reveals biological differences in acute myeloid leukemia with isolated trisomy 8 and normal cytogenetics Proc Natl Acad Sci USA 2001 98: 1124–1129

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Andersen, M., Pedersen-Bjergaard, J., Kjeldsen, L. et al. Clonal Ph-negative hematopoiesis in CML after therapy with imatinib mesylate is frequently characterized by trisomy 8. Leukemia 16, 1390–1393 (2002). https://doi.org/10.1038/sj.leu.2402634

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.leu.2402634

This article is cited by

Search

Quick links